| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lecithin — a heterogeneous mixture of phospholipids (primarily phosphatidylcholine [PC], phosphatidylethanolamine [PE], phosphatidylinositol [PI], phosphatidylserine [PS]) derived from soy, sunflower, egg yolk, or marine sources. Used as a dietary supplement, emulsifier, and drug-delivery excipient. Primary mechanisms (conceptual rank): Bioavailability / PK relevance: Orally digested to lysophospholipids + choline; re-esterified and incorporated into lipoproteins/cell membranes. Systemic effects reflect nutrient flux, not direct pharmacologic signaling. In-vitro vs oral exposure: Many membrane or apoptosis effects seen in vitro are concentration-dependent and not reflective of typical dietary intake. Clinical evidence status: Nutritional supplement; evidence strongest for hepatic lipid metabolism and choline deficiency states. No validated anti-cancer indication. Lecithin a phospholipid-rich compound (often derived from soy or sunflower), can enhance the bioavailability of certain lipophilic (fat-soluble) and amphipathic compounds by improving their solubility, absorption, and cellular uptake.Supplements and Compounds with Improved Bioavailability via Lecithin Curcumin Up to 20–30x better absorption in some formulations Quercetin Resveratrol Silybin (from milk thistle) Green tea catechins, EGCG Lecithin helps stabilize and protect catechins during digestion Boswellic acids Coenzyme Q10 (CoQ10) Omega-3 fatty acids Vitamin D, E, A, K (Fat-soluble vitamins) Alpha-lipoic acid (ALA) black seed oil (Nigella sativa) and its key active compound, thymoquinone. Lecithin — Cancer vs Normal Cell Pathway Map
TSF legend: |
| Source: HalifaxProj(inhibit) |
| Type: |
| Cyclooxygenase-2 (COX-2) is an enzyme that plays a critical role in the conversion of arachidonic acid to prostaglandins, which are lipid compounds involved in various physiological processes, including inflammation, pain, and fever. COX-2 is an inducible enzyme, meaning its expression is typically low in normal tissues but can be upregulated in response to inflammatory stimuli, growth factors, and certain oncogenic signals. -Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in prostaglandin biosynthesis, plays a key role in inflammation and circulatory homeostasis. -COX-2 is an inducible enzyme that is upregulated in response to pro-inflammatory signals, including cytokines (e.g., IL-1β, TNF-α) and growth factors. COX-2 is often overexpressed in various tumors, including colorectal, breast, lung, and prostate cancers. The prostaglandins produced by COX-2, particularly prostaglandin E2 (PGE2), have several effects that can facilitate cancer progression: Cell Proliferation: PGE2 can promote the proliferation of cancer cells by activating signaling pathways such as the PI3K/Akt and MAPK pathways. Nonselective NSAIDs, such as aspirin and ibuprofen, inhibit both COX-1 and COX-2. Epidemiological studies have suggested that regular use of NSAIDs may reduce the risk of certain cancers, particularly colorectal cancer. Drugs specifically targeting COX-2, such as celecoxib, have been developed. COX-2 and xanthine oxidase are ROS-producing pro-oxidant enzymes that contribute to inflammation. Elevated COX‑2 levels, often found in inflammatory conditions or certain types of cancers, can contribute to increased production of ROS. |
| 1792- | CUR, | LEC, | Chondroprotective effect of curcumin and lecithin complex in human chondrocytes stimulated by IL-1β via an anti-inflammatory mechanism |
| - | in-vitro, | Arthritis, | RAW264.7 | - | NA, | NA, | HCC-38 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:114 Target#:66 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid